SCHEMBL4156749

SCHEMBL4156749

CN(C(=O)c1c(F)cccc1F)C(=O)N(C)c1c(F)cc(SC(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
TLR7 Q9NYK1 1/20 0.34
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
RORC P51449 4/20 0.31
MAPT P10636 2/20 0.31
HTT P42858 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GPBAR1 Q8TDU6 1/20 0.31
RORA P35398 1/20 0.31
RORB Q92753 1/20 0.31
LMNA P02545 2/20 0.30
TSHR P16473 2/20 0.30
MAPK1 P28482 1/20 0.30
ALDH1A1 P00352 1/20 0.30
ERN1 O75460 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636164 0.87 CES2 (0.37) POLBCES2CES1MAPTHTT
SCHEMBL4154435 0.85 RORC (0.36) POLBTDP1TLR7CES2CES1
SCHEMBL4159049 0.84 TLR7 (0.39) POLBTDP1TLR7CES2CES1
SCHEMBL4149997 0.81 RORC (0.41) TDP1TLR7RORCRORARORB
SCHEMBL4155292 0.81 RORC (0.38) POLBTDP1TLR7RORCMAPT
SCHEMBL4150987 0.79 TRPA1 (0.36) POLBTLR7
SCHEMBL4162997 0.78 RORC (0.46) TLR7RORCRORARORB
SCHEMBL4150843 0.78 POLB (0.36) POLBTDP1TLR7CES2CES1
SCHEMBL4159052 0.78 TDP1 (0.37) POLBTDP1TLR7CES2CES1
SCHEMBL5312744 0.77 ABL1 (0.34) POLBTDP1RORCMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 POLB 4024/4885TDP1 1690/4885TLR7 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.